These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 11647960)
1. When the dying enroll in studies: a debate over false hopes. Kolata G N Y Times Web; 1994 Jan; ():7. PubMed ID: 11647960 [No Abstract] [Full Text] [Related]
2. Considering experimentation and elusive truth: informed consent made difficult. Brodeur D Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444 [No Abstract] [Full Text] [Related]
3. Human experimentation. Protecting patient autonomy through informed consent. Tuthill KA J Leg Med; 1997 Jun; 18(2):221-50. PubMed ID: 9230568 [No Abstract] [Full Text] [Related]
4. A researcher's concern with ethics in human research. Levine RH J Calif Alliance Ment Ill; 1994; 5(1):6-8. PubMed ID: 11653328 [No Abstract] [Full Text] [Related]
5. Informed consent in medical experimentation. Burgess MM Ann R Coll Physicians Surg Can; 1987 Jan; 20(1):29-31. PubMed ID: 11649817 [No Abstract] [Full Text] [Related]
6. Research involving the vulnerable sick. Weijer C Account Res; 1999; 7(1):21-36. PubMed ID: 11657560 [No Abstract] [Full Text] [Related]
7. Subject selection for clinical trials. American Medical Association. Council on Ethical and Judicial Affairs IRB; 1998; 20(2-3):12-5. PubMed ID: 11656913 [No Abstract] [Full Text] [Related]
8. The standard of disclosure in human subject experimentation. Morin K J Leg Med; 1998 Jun; 19(2):157-221. PubMed ID: 9658739 [No Abstract] [Full Text] [Related]
9. The ethics of phase I pediatric oncology trials. Ackerman TF IRB; 1995; 17(1):1-5. PubMed ID: 11653060 [No Abstract] [Full Text] [Related]
10. American Academy of Pediatrics. Committee on Drugs. Guidelines for the ethical conduct of studies to evaluate drugs in pediatric populations. Pediatrics; 1977 Jul; 60(1):91-101. PubMed ID: 876741 [No Abstract] [Full Text] [Related]
11. The therapeutic misconception, beneficence, and respect. Fried E Account Res; 2001; 8(4):331-48. PubMed ID: 12481794 [TBL] [Abstract][Full Text] [Related]
12. An IRB member's perspective on access to innovative therapy. Moore DL Albany Law Rev; 1994; 57(3):559-81. PubMed ID: 11652854 [No Abstract] [Full Text] [Related]
13. The doctor's unproven belief and the subject's informed choice: another commentary. Marquis D; Stephens R; Levine RJ IRB; 1989; 11(3):8-11. PubMed ID: 11650208 [No Abstract] [Full Text] [Related]
14. Patient-funded research: paying the piper or protecting the patient? Morreim EH IRB; 1991; 13(3):1-6. PubMed ID: 11651046 [No Abstract] [Full Text] [Related]
15. Playing roulette with experimental drugs. Budiansky S US News World Rep; 1987 Jul; 103(2):58-9. PubMed ID: 11658841 [No Abstract] [Full Text] [Related]
16. Phase I cancer trials. A collusion of misunderstanding. Miller M Hastings Cent Rep; 2000; 30(4):34-43. PubMed ID: 10971892 [No Abstract] [Full Text] [Related]
17. Proposed guidelines for the participation of persons with dementia as research subjects. Keyserlingk EW; Glass K; Kogan S; Gauthier S Perspect Biol Med; 1995; 38(2):319-61. PubMed ID: 11644666 [No Abstract] [Full Text] [Related]
18. Research ethics and clinical trials: fostering collaboration with research participants. Phipps E; Fleetwood J; Piraino A Account Res; 1999; 6(3):215-26. PubMed ID: 11658125 [No Abstract] [Full Text] [Related]
20. The paradoxical case of payment as benefit to research subjects. Macklin R IRB; 1989; 11(6):1-3. PubMed ID: 11650284 [No Abstract] [Full Text] [Related] [Next] [New Search]